The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in Klinefelter's syndrome: the influence of vitamin D deficiency and hormonal status
- 26 June 2003
- Vol. 33 (4), 589-596
- https://doi.org/10.1016/s8756-3282(03)00205-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Type I Collagen Racemization and Isomerization and the Risk of Fracture in Postmenopausal Women: The OFELY Prospective StudyJournal of Bone and Mineral Research, 2002
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000
- Intermittent and Continuous Administration of the Bisphosphonate Ibandronate in Ovariohysterectomized Beagle Dogs: Effects on Bone Morphometry and Mineral PropertiesJournal of Bone and Mineral Research, 1999
- Bone density and risk of hip fracture in men and women: cross sectional analysisBMJ, 1997
- The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding studyBone, 1996
- The Psychoeducational Profile of Boys with Klinefelter SyndromeJournal of Learning Disabilities, 1996
- Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosisJournal of Bone and Mineral Research, 1994
- A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogsJournal of Bone and Mineral Research, 1993
- Osteoporosis in MenMedicine, 1990
- Acute effects of calcium infusion on hydroxyprolineClinica Chimica Acta; International Journal of Clinical Chemistry, 1967